COVID-19: DIAGNOSTIC METHODS AND RECENT ADVANCES IN TREATMENT

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 stimulated rapid development of molecular diagnostics, rapid antigen tests, serological assays, imaging approaches and emerging point-of-care technologies. Accurate diagnosis supports clinical management, infection-control decisions, surveillance and timely identification of patients who may benefit from antiviral therapy. Nucleic-acid amplification tests, particularly reverse transcription polymerase chain reaction (RT-PCR), remain important laboratory methods for detecting viral RNA, while rapid antigen tests provide faster results and are useful for point-of-care and self-testing. Serological assays detect host antibodies and have more limited roles in early diagnosis. Newer approaches include reverse transcription loop-mediated isothermal amplification (RT-LAMP), CRISPR-based detection, biosensors, microfluidic platforms and multiplex respiratory pathogen assays. Treatment has evolved from predominantly supportive care toward risk- and severity-based management. Antiviral therapy is most relevant during the early viral-replication phase in patients at increased risk of progression, while corticosteroids and selected immunomodulators are used mainly in appropriately selected patients with severe or critical disease. Nirmatrelvir/ritonavir and remdesivir are important antiviral options in current clinical guidance, whereas molnupiravir has a more restricted role. Supportive respiratory care, oxygen therapy and management of complications remain essential. This review summarizes established and emerging diagnostic methods, current therapeutic strategies, limitations, and future directions in COVID-19 management.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-14
DOI
https://doi.org/10.5281/zenodo.24215787
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

COVID-19: DIAGNOSTIC METHODS AND RECENT ADVANCES IN TREATMENT

Payal Ubale, Ghadge Murlidhar
Zenodo (CERN European Organization for Nuclear Research)
SARS-CoV-2 detection and testing
article

COVID-19: DIAGNOSTIC METHODS AND RECENT ADVANCES IN TREATMENT

Payal Ubale, Ghadge Murlidhar
article en

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 stimulated rapid development of molecular diagnostics, rapid antigen tests, serological assays, imaging approaches and emerging point-of-care technologies. Accurate diagnosis supports clinical management, infection-control decisions, surveillance and timely identification of patients who may benefit from antiviral therapy. Nucleic-acid amplification tests, particularly reverse transcription polymerase chain reaction (RT-PCR), remain important laboratory methods for detecting viral RNA, while rapid antigen tests provide faster results and are useful for point-of-care and self-testing. Serological assays detect host antibodies and have more limited roles in early diagnosis. Newer approaches include reverse transcription loop-mediated isothermal amplification (RT-LAMP), CRISPR-based detection, biosensors, microfluidic platforms and multiplex respiratory pathogen assays. Treatment has evolved from predominantly supportive care toward risk- and severity-based management. Antiviral therapy is most relevant during the early viral-replication phase in patients at increased risk of progression, while corticosteroids and selected immunomodulators are used mainly in appropriately selected patients with severe or critical disease. Nirmatrelvir/ritonavir and remdesivir are important antiviral options in current clinical guidance, whereas molnupiravir has a more restricted role. Supportive respiratory care, oxygen therapy and management of complications remain essential. This review summarizes established and emerging diagnostic methods, current therapeutic strategies, limitations, and future directions in COVID-19 management.

Zenodo (CERN European Organization for Nuclear Research)
Dr. Babasaheb Ambedkar Technological University (IN)
SARS-CoV-2 detection and testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon